http://chineseinput.net/에서 pinyin(병음)방식으로 중국어를 변환할 수 있습니다.
변환된 중국어를 복사하여 사용하시면 됩니다.
Liu, Jianfang,Lichtenberg, Tara,Hoadley, Katherine A.,Poisson, Laila M.,Lazar, Alexander J.,Cherniack, Andrew D.,Kovatich, Albert J.,Benz, Christopher C.,Levine, Douglas A.,Lee, Adrian V.,Omberg, Lars Elsevier 2018 Cell Vol.173 No.2
<P><B>Summary</B></P> <P>For a decade, The Cancer Genome Atlas (TCGA) program collected clinicopathologic annotation data along with multi-platform molecular profiles of more than 11,000 human tumors across 33 different cancer types. TCGA clinical data contain key features representing the democratized nature of the data collection process. To ensure proper use of this large clinical dataset associated with genomic features, we developed a standardized dataset named the TCGA Pan-Cancer Clinical Data Resource (TCGA-CDR), which includes four major clinical outcome endpoints. In addition to detailing major challenges and statistical limitations encountered during the effort of integrating the acquired clinical data, we present a summary that includes endpoint usage recommendations for each cancer type. These TCGA-CDR findings appear to be consistent with cancer genomics studies independent of the TCGA effort and provide opportunities for investigating cancer biology using clinical correlates at an unprecedented scale.</P> <P><B>Highlights</B></P> <P> <UL> <LI> Generation of TCGA Clinical Data Resource for 11,160 patients over 33 cancer types </LI> <LI> Analysis of clinical outcome endpoints with usage recommendations for each cancer </LI> <LI> Demonstration of data validity and utility for large-scale translational research </LI> </UL> </P> <P><B>Graphical Abstract</B></P> <P>[DISPLAY OMISSION]</P>